For: | Marin Garcia PJ, Marin-Castaño ME. Angiotensin II-related hypertension and eye diseases. World J Cardiol 2014; 6(9): 968-984 [PMID: 25276298 DOI: 10.4330/wjc.v6.i9.968] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v6/i9/968.htm |
Number | Citing Articles |
1 |
Ashok Sharma, Maria L. Valle, Connor Beveridge, Yutao Liu, Shruti Sharma. Unraveling the role of genetics in the pathogenesis of diabetic retinopathy. Eye 2019; 33(4): 534 doi: 10.1038/s41433-019-0337-y
|
2 |
Nayara Azinheira Nobrega Cruz, Lilian Caroline Gonçalves de Oliveira, Mauro Silveira de Queiroz Campos, Preenie de Senanayake, Dulce Elena Casarini. Angiotensin. 2023; : 419 doi: 10.1016/B978-0-323-99618-1.00015-5
|
3 |
Saba Saleem, Aisha Azam, Sundus Ijaz Maqsood, Irfan Muslim, Shaheena Bashir, Nosheen Fazal, Moeen Riaz, Syeda Hafiza Benish Ali, Muhammad Khizar Niazi, Mazhar Ishaq, Nadia Khalida Waheed, Raheel Qamar, Maleeha Azam, Alexander V. Ljubimov. Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy. PLOS ONE 2015; 10(12): e0144557 doi: 10.1371/journal.pone.0144557
|
4 |
Mustafa ÖZGÜR, Aslı UÇAR. Yaşa bağlı makular dejenerasyonu olan hastaların beslenme durumlarının değerlendirilmesi. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi 2018; 9(1): 20 doi: 10.22312/sdusbed.368758
|
5 |
Mong-Heng Wang, Ahmed S. Ibrahim, George Hsiao, Amany Tawfik, Mohamed Al-Shabrawey. A novel interaction between soluble epoxide hydrolase and the AT1 receptor in retinal microvascular damage. Prostaglandins & Other Lipid Mediators 2020; 148: 106449 doi: 10.1016/j.prostaglandins.2020.106449
|
6 |
Tapan Behl, Anita Kotwani. Potential of angiotensin II receptor blockers in the treatment of diabetic retinopathy. Life Sciences 2017; 176: 1 doi: 10.1016/j.lfs.2017.03.020
|
7 |
Yong Li, Guangsi Shen, Chen Yu, Guangfei Li, Junkang Shen, Jianping Gong, Youjia Xu. Angiotensin II induces mitochondrial oxidative stress and mtDNA damage in osteoblasts by inhibiting SIRT1–FoxO3a–MnSOD pathway. Biochemical and Biophysical Research Communications 2014; 455(1-2): 113 doi: 10.1016/j.bbrc.2014.10.123
|
8 |
Norihiro Nagai, Hirohiko Kawashima, Eriko Toda, Kohei Homma, Hideto Osada, Naymel A. Guzman, Shinsuke Shibata, Yasuo Uchiyama, Hideyuki Okano, Kazuo Tsubota, Yoko Ozawa. Renin–angiotensin system impairs macrophage lipid metabolism to promote age-related macular degeneration in mouse models. Communications Biology 2020; 3(1) doi: 10.1038/s42003-020-01483-2
|
9 |
Seema Patel, Abdur Rauf, Haroon Khan, Tareq Abu-Izneid. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies. Biomedicine & Pharmacotherapy 2017; 94: 317 doi: 10.1016/j.biopha.2017.07.091
|
10 |
Sarfaraz Ahmad, Kendra N. Wright, Jessica L. VonCannon, Carlos M. Ferrario, Mohammad S. Ola, Mayur Choudhary, Goldis Malek, Jenna R. Gustafson, Rebecca M. Sappington. Internalization of Angiotensin-(1–12) in Adult Retinal Pigment Epithelial-19 Cells. Journal of Ocular Pharmacology and Therapeutics 2023; 39(4): 290 doi: 10.1089/jop.2022.0139
|
11 |
Selma Alin Somilleda-Ventura, Yatzul Zuhaila García-Rubio, Dulce Milagros Razo Blanco-Hernández, Virgilio Lima-Gómez. Association between visual improvement after photocoagulation and the use of angiotensin converting enzyme inhibitors in diabetic macular oedema. Cirugía y Cirujanos (English Edition) 2016; 84(4): 269 doi: 10.1016/j.circen.2016.06.006
|
12 |
Abdelrahman Y. Fouda, Sandeep Artham, Azza B. El-Remessy, Susan C. Fagan. Renin–angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence. Clinical Science 2016; 130(4): 221 doi: 10.1042/CS20150350
|
13 |
Sónia Simão, Daniela F. Santos, Gabriela A. Silva. Aliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cells. Angiogenesis 2017; 20(1): 175 doi: 10.1007/s10456-016-9526-5
|
14 |
Mervi Holappa, Heikki Vapaatalo, Anu Vaajanen. Many Faces of Renin-angiotensin System - Focus on Eye. The Open Ophthalmology Journal 2017; 11(1): 122 doi: 10.2174/1874364101711010122
|
15 |
Danielle Gomes Passos-Silva, Enrique Brandan, Robson Augusto Souza Santos. Angiotensins as therapeutic targets beyond heart disease. Trends in Pharmacological Sciences 2015; 36(5): 310 doi: 10.1016/j.tips.2015.03.001
|
16 |
Vidya P. Kumar, Yali Kong, Riana Dolland, Sandra R. Brown, Kan Wang, Damian Dolland, David Mu, Milton L. Brown. Exploring Angiotensin II and Oxidative Stress in Radiation-Induced Cataract Formation: Potential for Therapeutic Intervention. Antioxidants 2024; 13(10): 1207 doi: 10.3390/antiox13101207
|
17 |
Aurora Mazzeo, Ana I. Arroba, Elena Beltramo, Angela M. Valverde, Massimo Porta. Somatostatin protects human retinal pericytes from inflammation mediated by microglia. Experimental Eye Research 2017; 164: 46 doi: 10.1016/j.exer.2017.07.011
|
18 |
Shuai Wang, Jing Li, Tong Wang, Jie Bai, Yun-Long Zhang, Qiu-Yue Lin, Jing-min Li, Qi Zhao, Shu-Bin Guo, Hui-Hua Li. Ablation of Immunoproteasome β5i Subunit Suppresses Hypertensive Retinopathy by Blocking ATRAP Degradation in Mice. Molecular Therapy 2020; 28(1): 279 doi: 10.1016/j.ymthe.2019.09.025
|
19 |
Longzhu Liu, Yi Lu, Xueyuan Bi, Man Xu, Xiaojiang Yu, Runqing Xue, Xi He, Weijin Zang. Choline ameliorates cardiovascular damage by improving vagal activity and inhibiting the inflammatory response in spontaneously hypertensive rats. Scientific Reports 2017; 7(1) doi: 10.1038/srep42553
|
20 |
Mervi Holappa, Heikki Vapaatalo, Anu Vaajanen. Ocular renin-angiotensin system with special reference in the anterior part of the eye. World Journal of Ophthalmology 2015; 5(3): 110-124 doi: 10.5318/wjo.v5.i3.110
|
21 |
Yogesh S. Ahire, Vinod A. Bairagi, Deepak B. Somavanshi, Smruti R. Jadhav, Swapnil B. Jadhav, Shekhar D. Jagtap. Expanding telmisartan’s therapeutic horizon: exploring its multifaceted mechanisms beyond cardiovascular disorders. Future Journal of Pharmaceutical Sciences 2024; 10(1) doi: 10.1186/s43094-024-00655-9
|
22 |
Amrisha Verma, Ping Zhu, Annette de Kloet, Eric Krause, Colin Sumners, Qiuhong Li. Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells. Experimental Eye Research 2019; 187: 107770 doi: 10.1016/j.exer.2019.107770
|
23 |
Xiaonan Zhang, Shaoyang Dong, Qiujin Jia, Ao Zhang, Yanyang Li, Yaping Zhu, Shichao Lv, Junping Zhang. The microRNA in ventricular remodeling: the miR-30 family. Bioscience Reports 2019; 39(8) doi: 10.1042/BSR20190788
|
24 |
Sidra Sarwat, Fiona Stapleton, Mark Willcox, Maitreyee Roy. Quantum Dots in Ophthalmology: A Literature Review. Current Eye Research 2019; 44(10): 1037 doi: 10.1080/02713683.2019.1660793
|
25 |
Mong-Heng Wang, George Hsiao, Mohamed Al-Shabrawey. Eicosanoids and Oxidative Stress in Diabetic Retinopathy. Antioxidants 2020; 9(6): 520 doi: 10.3390/antiox9060520
|
26 |
Elena Beltramo, Tatiana Lopatina, Aurora Mazzeo, Ana I. Arroba, Angela M. Valverde, Cristina Hernández, Rafael Simó, Massimo Porta. Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy. Acta Diabetologica 2016; 53(6): 957 doi: 10.1007/s00592-016-0895-4
|
27 |
Mervi Holappa, Heikki Vapaatalo, Anu Vaajanen. Local ocular renin–angiotensin–aldosterone system: any connection with intraocular pressure? A comprehensive review. Annals of Medicine 2020; 52(5): 191 doi: 10.1080/07853890.2020.1758341
|
28 |
Selma Alin Somilleda-Ventura, Yatzul Zuhaila García-Rubio, Dulce Milagros Razo Blanco-Hernández, Virgilio Lima-Gómez. Asociación entre la mejoría visual y el uso de inhibidores de la enzima convertidora de angiotensina, en edema macular diabético. Cirugía y Cirujanos 2016; 84(4): 269 doi: 10.1016/j.circir.2015.09.004
|
29 |
Natarajan Perumal, Lars Straßburger, David P. Herzog, Marianne B. Müller, Norbert Pfeiffer, Franz H. Grus, Caroline Manicam. Bioenergetic shift and actin cytoskeleton remodelling as acute vascular adaptive mechanisms to angiotensin II in murine retina and ophthalmic artery. Redox Biology 2020; 34: 101597 doi: 10.1016/j.redox.2020.101597
|
30 |
Xin Li, Yu-Hong Fu, Xue-Wei Tong, Yi-Tong Zhang, Yong-Yan Shan, Yu-Xin Xu, Sheng-Dan Pu, Xin-Yuan Gao. RAAS in diabetic retinopathy: mechanisms and therapies. Archives of Endocrinology and Metabolism 2024; 68 doi: 10.20945/2359-4292-2023-0292
|